Alternatives to Animal Experiments

Introduction & rationale

• Definition — "alternatives to animal experiments" are methods that replace, reduce or refine the use of whole animals in biomedical research while still meeting the same evidentiary standards of efficacy and safety in preclinical and clinical study.
• Why the topic exists — researchers face the recurring allegation that animal use "is not necessary" because drugs can be developed in the test-tube, by computer (in silico), or by microdosing healthy volunteers — these three routes are the conceptual backbone of all alternatives.
• Core ethical premise — "each animal has a right to life"; pain or suffering is unethical unless for that animal's (or, by analogy, the patient's) direct benefit. Research with low suffering and high benefit is generally regarded as acceptable.
• Realistic scope — animal use can be minimised but not entirely eliminated today — alternatives target the heaviest-use stage, Stage II preclinical (pharmacodynamics, pharmacokinetics, acute/chronic/genotoxicity) of the three-stage pipeline (lead discovery → preclinical → clinical).
• Model validity — an animal is a valid model only when, despite differences, it strongly resembles humans in the feature studied — model choice favours a species phylogenetically closer to man with similar anatomy, physiology and biochemistry.